(Q44437793)

3 December 2017

0 references

Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis (English)

1 reference

3 December 2017

1 reference

1 reference

1

1 reference

3 December 2017

W Scott Beattie

2

1 reference

3 December 2017

Vivek Rao

series ordinal

3

1 reference

3 December 2017

Jacek Karski

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1496-1505

1 reference

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Early postoperative spasm in left internal mammary artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

New Uses for Calcium Channel Blockers : Therapeutic Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Calcium channel blockade does not offer adequate protection from perioperative myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effect of calcium antagonist diltiazem on renal function in open heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Myocardial protection by perioperative diltiazem drip: a clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Verapamil prophylaxis for postoperative atrial dysrhythmias: a prospective, randomized, double-blind study using drug level monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effect of peri-operative diltiazem on myocardial ischaemia and function in patients receiving mammary artery grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

[Prevention of myocardial ischemia. Study following aortocoronary bypass operation with the calcium antagonist diltiazem]

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Cardioprotective effects of diltiazem infusion in the perioperative period

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nitroglycerin is preferable to diltiazem for prevention of coronary bypass conduit spasm.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Oral verapamil fails to prevent supraventricular tachycardia following coronary artery surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Perioperative myocardial protection with the calcium antagonist diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effects of a continuous diltiazem infusion on renal function during cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Calcium channel blockers: an intraoperative and postoperative trial in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nicardipine for preservation of myocardial metabolism and function in patients undergoing coronary artery surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Intravenous nifedipine to treat hypertension after coronary artery revascularization surgery. A comparison with sodium nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Infusion of nifedipine after coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Comparison of nitroglycerine, verapamil and nifedipine in the management of arterial pressure during coronary artery surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effect of hypothermia on the coagulation cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Verapamil and myocardial preservation in patients undergoing coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Assessing the quality of randomized trials: reliability of the Jadad scale

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

Should unpublished data be included in meta-analyses? Current convictions and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900191-8

7 January 2021

10.1016/S0735-1097(03)00191-8

Identifiers

DOI

1 reference

release_ecutw5tcg5ek7iisyyfh3ikxie

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ecutw5tcg5ek7iisyyfh3ikxie

24 November 2022

mapped directly with Wikidata item

1 reference